Sanara MedTech (SMTI) Gross Profit (2010 - 2026)

Sanara MedTech has reported Gross Profit for 16 years, with the latest figure at $25.9 million in Q1 2026.

• For the quarter ending Q1 2026, Gross Profit rose 19.8% year-over-year to $25.9 million; the trailing twelve-month figure through Mar 2026 stood at $99.9 million (up 19.66% YoY), and the FY2025 full-year result was $95.6 million, up 21.73% from the prior year.
• Gross Profit for Q1 2026 stood at $25.9 million, up from $25.7 million in the prior quarter.
• The five-year high for Gross Profit was $25.9 million in Q1 2026, with the low at $7.0 million in Q1 2022.
• Historically, Gross Profit has averaged $17.5 million across 5 years, with a median of $16.6 million in 2024.
• Annual changes were most pronounced in 2022 — Gross Profit surged 107.13% — and 2025, when it climbed 6.71%.
• Sanara MedTech's Gross Profit stood at $12.9 million in 2022, then rose by 22.82% to $15.9 million in 2023, then surged by 51.28% to $24.1 million in 2024, then rose by 6.71% to $25.7 million in 2025, then advanced by 0.79% to $25.9 million in 2026.
• The last three Gross Profit figures came in at $25.9 million (Q1 2026), $25.7 million (Q4 2025), and $24.5 million (Q3 2025), per Business Quant data.